The Transcription Factor Lymphoid Enhancer Factor 1 Controls Invariant Natural Killer T Cell Expansion and Th2-type Effector Differentiation
Overview
General Medicine
Affiliations
Invariant natural killer T cells (iNKT cells) are innate-like T cells that rapidly produce cytokines that impact antimicrobial immune responses, asthma, and autoimmunity. These cells acquire multiple effector fates during their thymic development that parallel those of CD4(+) T helper cells. The number of Th2-type effector iNKT cells is variable in different strains of mice, and their number impacts CD8 T, dendritic, and B cell function. Here we demonstrate a unique function for the transcription factor lymphoid enhancer factor 1 (LEF1) in the postselection expansion of iNKT cells through a direct induction of the CD127 component of the receptor for interleukin-7 (IL-7) and the transcription factor c-myc. LEF1 also directly augments expression of the effector fate-specifying transcription factor GATA3, thus promoting the development of Th2-like effector iNKT cells that produce IL-4, including those that also produce interferon-γ. Our data reveal LEF1 as a central regulator of iNKT cell number and Th2-type effector differentiation.
Akula S, Alvarado-Vazquez A, Haide Mendez Enriquez E, Bal G, Franke K, Wernersson S Int J Mol Sci. 2024; 25(23).
PMID: 39684762 PMC: 11642334. DOI: 10.3390/ijms252313050.
Transcriptomic diversity of innate lymphoid cells in human lymph nodes compared to BM and spleen.
Hashemi E, McCarthy C, Rao S, Malarkannan S Commun Biol. 2024; 7(1):769.
PMID: 38918571 PMC: 11199704. DOI: 10.1038/s42003-024-06450-9.
Maas-Bauer K, Kohler N, Stell A, Zwick M, Acharya S, Rensing-Ehl A J Leukoc Biol. 2023; 115(2):401-409.
PMID: 37742056 PMC: 10799303. DOI: 10.1093/jleuko/qiad113.
Zhao W, Wang Y, Zhang X, Hao J, Zhang K, Huang X Front Immunol. 2023; 14:1203614.
PMID: 37600815 PMC: 10438461. DOI: 10.3389/fimmu.2023.1203614.
LEF1 Drives a Central Memory Program and Supports Antitumor Activity of Natural Killer T Cells.
Ngai H, Barragan G, Tian G, Balzeau J, Zhang C, Courtney A Cancer Immunol Res. 2022; 11(2):171-183.
PMID: 36484736 PMC: 9898189. DOI: 10.1158/2326-6066.CIR-22-0333.